The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. While using information , double check the authenticity of information. There is a chance of error in information. If you identify the error please pass the message to Drugbank administrator.
The database contains 6729 drug entries
- 1465 FDA-approved small molecule drugs,
- 132 FDA-approved biotech (protein/peptide) drugs,
- 86 nutraceuticals and 5076 experimental drugs. Additionally,
- 4254 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries.
- Each DrugCard entry contains more than 150 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data.
DrugBank is supported by David Wishart, Departments of Computing Science & Biological Sciences, University of Alberta.
DrugBank is also supported by The Metabolomics Innovation Centre, a Genome Canada-funded core facility serving the scientific community and industry with world-class expertise and cutting-edge technologies in metabolomics.